(success)
TH
EN
A-
A+
A-
A+
Dr.Pattranuch Chusri

Dr.Pattranuch Chusri

Lecturer

Tel: +66 (0) 5391 6575
Email: pattranuch.chu@mfu.ac.th

Education

  • Doctor of Philosophy in Microbiology, Chiang Mai University, Thailand (2014)
  • Bachelor of Science in Medical Technology, Chiang Mai University, Thailand (2008)
Speciallization

  • Medical microbiology
  • Medical virology
  • Molecular biology
Awards/Publications

Chusri P, Kumthip K, Hong J, Zhu C, Jilg N, Fusco DN, Brisac C, Schaefer EA, Cai D, Peng LF, Maneekarn N, Lin W, Chung RT (2016), HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep. 2016; 6:22487

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT (2015), EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus
Infection through the RIG-I/MDA5 Pathway. J Virol. 2015; 89:6608-18

Chusri P, Kumthip K, Pantip C, Thongsawat S, O'Brien A, Maneekarn N. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy. Virus Res. 2015; 196:37-43

Kumthip K, Chusri P, Pantip C, Thongsawat S, O'Brien A, Nelson KE, Maneekarn N. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy. J Med Virol. 2014; 86:1360-5

Jilg N, Lin W, Hong J, Schaefer EA, Wolski D, Meixong J, Goto K, Brisac C, Chusri P, Fusco DN, Chevaliez S, Luther J, Kumthip K, Urban TJ, Peng LF, Lauer GM, Chung RT. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 2014; 59:1250-61

Kumthip K, Chusri P, Jilg N, Zhao L, Fusco DN, Zhao H, Goto K, Cheng D, Schaefer EA, Zhang L, Pantip C, Thongsawat S, O’Brien A, Peng LF, Maneekarn N, Chung RT, Lin W. HCV NS5A disrupts STAT1 phosphorylation and suppresses type I IFN signaling. J Virol. 2012;86:8581-91

Kumthip K, Pantip C, Chusri P, Thongsawat S, O'Brien A, Nelson KE, Maneekarn N. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy. J Virol Hepat. 2011; 18:e117-25

Khamrin P, Thongprachum A, Chaimongkol N, Chusri P, Okitsu S, Ushijima H, Maneekarn N. Evolutionary consequences of G9 rotaviruses circulating in Thailand. Infect Genet Evol. 2009; 9:1394-9